Individualised high-dose busulfan in paediatric patients undergoing haematopoietic stem cell transplantation

被引：0
|
作者：
Badell, I [1 ]
Farré, R [1 ]
López, E [1 ]
Pardo, N [1 ]
Torrent, M [1 ]
Sánchez, A [1 ]
Losa, L [1 ]
Juanals, MT [1 ]
Clopés, A [1 ]
Cubells, J [1 ]
Mangues, MA [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S333 / S333
页数：1
相关论文
共 50 条
  • [31] CNS TOXICITY AND HIGH-DOSE BUSULFAN IN 3 PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
    VASTA, S
    SCIME, R
    INDOVINA, A
    MAJOLINO, I
    [J]. HAEMATOLOGICA, 1992, 77 (02) : 189 - 189
  • [32] ORAL LORAZEPAM PREVENTS SEIZURE DURING HIGH-DOSE BUSULFAN IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A Prospective Study
    Hamidieh, Amir Ali
    Hamedani, Ravak
    Hadjibabaie, Molouk
    Amini, Mohsen
    Sadrai, Sima
    Ghavamzadeh, Ardeshir
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (07) : 529 - 533
  • [33] Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies
    HT Tran
    T Madden
    D Petropoulos
    LL Worth
    EA Felix
    HA Sprigg-Saenz
    M Choroszy
    M Danielson
    D Przepiorka
    K-W Chan
    [J]. Bone Marrow Transplantation, 2000, 26 : 463 - 470
  • [34] Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies
    Tran, HT
    Madden, T
    Petropoulos, D
    Worth, LL
    Felix, EA
    Sprigg-Saenz, HA
    Choroszy, M
    Danielson, M
    Przepiorka, D
    Chan, KW
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (05) : 463 - 470
  • [35] Population Pharmacokinetic Study of a Test Dose Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation
    Nogueira, Iracema Esteves
    Fernandes, Juliana
    Sugawara, Eduardo K.
    de Oliveira, Jose Salvador
    Gouveia, Roseane
    Rodrigues, Morgani
    Barros, Daniele Porto
    Diniz, Mariane Pereira
    de Souza Santos, Fabio P.
    Ribeiro, Andreza Feitosa
    Sobrinho, Jairo J. N.
    Nakashima, Sandra Saemi
    de Lima, Marcos
    Hamerschlak, Nelson
    Kerbauy, Fabio R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S265 - S265
  • [36] Paediatric haematopoietic stem cell transplantation in Iran
    Ghavamzadeh, A.
    Hamidieh, A. A.
    Jahani, M.
    Alimoghaddam, K.
    Mousavi, A.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Nedaiefard, L.
    Ashouri, A.
    Basirpanah, S.
    Mousavi, A.
    Shahriari, Z.
    Khalilvand, S.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S294 - S294
  • [37] Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients Towards Individualized Dosing
    Bartelink, Imke H.
    Boelens, Jaap J.
    Bredius, Robbert G. M.
    Egberts, Antoine C. G.
    Wang, Chenguang
    Bierings, Marc B.
    Shaw, Peter J.
    Nath, Christa E.
    Hempe, George
    Zwaveling, Juliette
    Danhof, Meindert
    Knibbe, Catherijne A. J.
    [J]. CLINICAL PHARMACOKINETICS, 2012, 51 (05) : 331 - 345
  • [38] 1,5-benzodiazepin clobazam is effective in preventing seizures in patients receiving high-dose oral or intraveneous busulfan as conditioning for allogeneic haematopoietic stem cell transplantation
    Schwerdtfeger, R
    Schleuning, M
    Judith, D
    Kaltenhäuser, J
    Baurmann, H
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S97 - S97
  • [39] Autologous haematopoietic stem cell transplantation following high-dose immunosuppressive therapy in neuromyelitis optica
    Bowen, J. D.
    Hagglund, H.
    Kraft, G. H.
    Wundes, A.
    Piehl, F.
    Storb, R.
    Georges, G. E.
    Maravilla, K.
    Nash, R. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 66 - 67
  • [40] Pharmacokinetics and immunogenicity of CG53135-05 for the prevention of oral mucositis in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation
    Schuster, MW
    Shore, TB
    Harpel, J
    Greenberg, J
    Jalilizeinali, B
    Possley, S
    Annino, V
    Hawthorne, T
    Halvorsen, Y
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S99 - S99
12345